Sponsor Pipeline

Tianjin Medical University Eye Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
1
Recruiting
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-27 NCT07728981 Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in… Early Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Early Phase 1
1
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07449247 PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for… Pre-myopia Not Yet Recruiting
Early Phase 1
NCT07728981 Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in… Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD Not Yet Recruiting
Not specified
NCT05728476 Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal… Diabetic Macular Edema Recruiting
NCT07106268 Aqueous Humor Proteome in Retinal Vein Occlusion With Macular Edema Retinal Vein Occlusion Active, Not Recruiting
NCT07119723 Environmental Factors and Myopia Prevalence Among Uyghur Students in Remote China Myopia Enrolling by Invitation
NCT07494799 Efficacy of Different Interventions for Progressive Myopia After Orthokeratology Lens Wear Progressive Myopia Not Yet Recruiting
NCT07691671 Impact of Various Myopia Management Strategies on Asthenopia Among Pediatric and… Myopia Not Yet Recruiting
Get alerts when Tianjin Medical University Eye Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free